Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity

Clinical Science

Volumn 129, Issue 12, 2015, Pages 1025-1036

  Zhao, Lina ^a   Fu, Zhuo ^a   Wu, Jing ^a,b   Aylor, Kevin W ^a   Barrett, Eugene J ^a   Cao, Wenhong ^c   Liu, Zhenqi ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c University of North Carolina   (United States)

Author keywords

Endothelial dysfunction; High fat diet; Inflammation; Insulin resistance; Muscle microvasculature; Obesity

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; NONSTEROID ANTIINFLAMMATORY AGENT; NOS3 PROTEIN, RAT; SALICYLATE SODIUM;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET INDUCED OBESITY; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; METABOLIC INSULIN RESISTANCE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR INSULIN RESISTANCE; VASCULITIS; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; LIPID DIET; METABOLISM; MICROCIRCULATION; OBESITY; PATHOPHYSIOLOGY; PHOSPHORYLATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TIME FACTOR; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMARKERS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MICROVESSELS; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SODIUM SALICYLATE; TIME FACTORS;

EID: 84983203439     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20150143     Document Type: Article

References (47)

1. Caballero, B. (2007) The global epidemic of obesity: an overview. Epidemiol. Rev. 29, 1-5
2. Stein, C.J. and Colditz, G.A. (2004) The epidemic of obesity. J. Clin. Endocrinol. Metab. 89, 2522-2525
3. Dandona, P., Aljada, A. and Bandyopadhyay, A. (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7
4. Shoelson, S.E., Herrero, L. and Naaz, A. (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132, 2169-2180
5. Kim, F., Pham, M., Maloney, E., Rizzo, N.O., Morton, G.J., Wisse, B.E., Kirk, E.A., Chait, A. and Schwartz, M.W. (2008) Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1982-1988
6. Caballero, A.E., Bousquet-Santos, K., Robles-Osorio, L., Montagnani, V., Soodini, G., Porramatikul, S., Hamdy, O., Nobrega, A.C. and Horton, E.S. (2008) Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance. Diabetes Care 31, 576-582
7. Caballero, A.E. (2003) Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes. Res. 11, 1278-1289
8. Jonk, A.M., Houben, A.J., de Jongh, R.T., Serne, E.H., Schaper, N.C. and Stehouwer, C.D. (2007) Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology 22, 252-260
9. Muris, D.M., Houben, A.J., Schram, M.T. and Stehouwer, C.D. (2013) Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev. Endocr. Metab. Disord. 14, 29-38
10. van Sloten, T.T., Henry, R.M., Dekker, J.M., Nijpels, G., Unger, T., Schram, M.T. and Stehouwer, C.D. (2014) Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension 64, 1299-1305
11. Steinberger, J. and Daniels, S.R. (2003) Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107, 1448-1453
12. Vincent, M.A., Clerk, L.H., Lindner, J.R., Klibanov, A.L., Clark, M.G., Rattigan, S. and Barrett, E.J. (2004) Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53, 1418-1423
13. Chai, W., Wang, W., Dong, Z., Cao, W. and Liu, Z. (2011) Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 60, 2939-2946
14. Chai, W., Zhang, X., Barrett, E.J. and Liu, Z. (2014) Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance. Diabetes 63, 2788-2799
15. Zhao, L., Chai, W., Fu, Z., Dong, Z., Aylor, K.W., Barrett, E.J., Cao, W. and Liu, Z. (2013) Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery. Circ. Res. 112, 1263-1271
16. Fu, Z., Zhao, L., Chai, W., Dong, Z., Cao, W. and Liu, Z. (2013) Ranolazine recruits muscle microvasculature and enhances insulin action in rats. J. Physiol. 591, 5235-5249
17. Fu, Z., Zhao, L., Aylor, K.W., Carey, R.M., Barrett, E.J. and Liu, Z. (2014) Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor. Hypertension 63, 1219-1227
18. Zhang, L., Vincent, M.A., Richards, S.M., Clerk, L.H., Rattigan, S., Clark, M.G. and Barrett, E.J. (2004) Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 53, 447-453
19. Meijer, R.I., De Boer, M.P., Groen, M.R., Eringa, E.C., Rattigan, S., Barrett, E.J., Smulders, Y.M. and Serne, E.H. (2012) Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation 19, 494-500
20. Liu, Z., Liu, J., Jahn, L.A., Fowler, D.E. and Barrett, E.J. (2009) Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J. Clin. Endocrinol. Metab. 94, 3543-3549
21. Liu, J., Jahn, L.A., Fowler, D.E., Barrett, E.J., Cao, W. and Liu, Z. (2011) Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J. Clin. Endocrinol. Metab. 96, 438-446
22. Clerk, L.H., Vincent, M.A., Jahn, L.A., Liu, Z., Lindner, J.R. and Barrett, E.J. (2006) Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55, 1436-1442
23. Eggleston, E.M., Jahn, L.A. and Barrett, E.J. (2013) Early microvascular recruitment modulates subsequent insulin-mediated skeletal muscle glucose metabolism during lipid infusion. Diabetes Care 36, 104-110
24. Wallis, M.G., Wheatley, C.M., Rattigan, S., Barrett, E.J., Clark, A.D. and Clark, M.G. (2002) Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes 51, 3492-3498
25. Vincent, M.A., Barrett, E.J., Lindner, J.R., Clark, M.G. and Rattigan, S. (2003) Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am. J. Physiol. Endocrinol. Metab. 285, E123-E129
26. Clerk, L.H., Rattigan, S. and Clark, M.G. (2002) Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 51, 1138-1145
27. Youd, J.M., Rattigan, S. and Clark, M.G. (2000) Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes 49, 1904-1909
28. Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J. and Karin, M. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198
29. Shoelson, S.E., Lee, J. and Goldfine, A.B. (2006) Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801
30. Yin, M.J., Yamamoto, Y. and Gaynor, R.B. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77-80
31. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M. and Shoelson, S.E. (2001) Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677
32. Goldfine, A.B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J. and Shoelson, S.E. (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 1, 36-43
33. Goldfine, A.B., Conlin, P.R., Halperin, F., Koska, J., Permana, P., Schwenke, D., Shoelson, S.E. and Reaven, P.D. (2013) A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia 56, 714-723
34. Chai, W., Liu, J., Jahn, L.A., Fowler, D.E., Barrett, E.J. and Liu, Z. (2011) Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. Diabetes Care 34, 1634-1638
35. Dong, Z., Chai, W., Wang, W., Zhao, L., Fu, Z., Cao, W. and Liu, Z. (2013) Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. Am. J. Physiol. Endocrinol. Metab. 304, E222-E228
36. Zhang, W.J., Wei, H., Hagen, T. and Frei, B. (2007) Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 104, 4077-4082
37. Chai, W., Wu, Y., Li, G., Cao, W., Yang, Z. and Liu, Z. (2008) Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. Am. J. Physiol. Endocrinol. Metab. 294, E183-E189
38. Wang, N., Chai, W., Zhao, L., Tao, L., Cao, W. and Liu, Z. (2013) Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment. Am. J. Physiol. Endocrinol. Metab. 304, E538-E545
39. Inyard, A.C., Clerk, L.H., Vincent, M.A. and Barrett, E.J. (2007) Contraction stimulates nitric oxide independent microvascular recruitment and increases muscle insulin uptake. Diabetes 56, 2194-2200
40. Park, S.Y., Cho, Y.R., Kim, H.J., Higashimori, T., Danton, C., Lee, M.K., Dey, A., Rothermel, B., Kim, Y.B., Kalinowski, A. et al. (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54, 3530-3540
41. Turner, N., Kowalski, G.M., Leslie, S.J., Risis, S., Yang, C., Lee-Young, R.S., Babb, J.R., Meikle, P.J., Lancaster, G.I., Henstridge, D.C. et al. (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56, 1638-1648
42. Solinas, G. and Karin, M. (2010) JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J. 24, 2596-2611
43. Carvalho-Filho, M.A., Ropelle, E.R., Pauli, R.J., Cintra, D.E., Tsukumo, D.M., Silveira, L.R., Curi, R., Carvalheira, J.B., Velloso, L.A. and Saad, M.J. (2009) Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia 52, 2425-2434
44. Fleischman, A., Shoelson, S.E., Bernier, R. and Goldfine, A.B. (2008) Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31, 289-294
45. Koska, J., Ortega, E., Bunt, J.C., Gasser, A., Impson, J., Hanson, R.L., Forbes, J., de Courten, B. and Krakoff, J. (2009) The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 52, 385-393
46. Goldfine, A.B., Fonseca, V., Jablonski, K.A., Pyle, L., Staten, M.A. and Shoelson, S.E. (2010) The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346-357
47. Kim, Y.B., Nikoulina, S.E., Ciaraldi, T.P., Henry, R.R. and Kahn, B.B. (1999) Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J. Clin. Invest. 104, 733-741